Strong Revenue Growth
ATEC reported a 22% revenue growth to $169 million in Q1 2025, with surgical revenue growing by 24% year-over-year.
Surgeon Adoption Increase
The number of surgeons utilizing ATEC procedures increased by 18%, contributing to a 17% procedural volume growth.
Adjusted EBITDA Improvement
Adjusted EBITDA was $11 million, representing an 800 basis point improvement compared to the prior year and marking the second best quarter ever for ATEC.
EOS Order Growth
Record EOS order volume fueled a 28% year-over-year increase in the order book, indicating strong demand for ATEC's informatics solutions.
Cash Flow Management
Free cash use improved by $55 million over Q1 2024, and ATEC ended the quarter with $153 million in cash on hand.
International Expansion Success
ATEC is making progress in international markets, including Australia, New Zealand, and Japan, with notable adoption of their lateral procedures.